Biodesix (BDSX) Short term Debt: 2021-2024
Historic Short term Debt for Biodesix (BDSX) over the last 3 years, with Jun 2024 value amounting to $5.8 million.
- Biodesix's Short term Debt fell 59.91% to $5.8 million in Q2 2024 from the same period last year, while for Jun 2024 it was $5.8 million, marking a year-over-year decrease of 59.91%. This contributed to the annual value of $21.9 million for FY2023, which is 111.36% up from last year.
- According to the latest figures from Q2 2024, Biodesix's Short term Debt is $5.8 million, which was down 69.59% from $19.2 million recorded in Q1 2024.
- Biodesix's 5-year Short term Debt high stood at $21.9 million for Q4 2023, and its period low was $5.8 million during Q2 2024.
- In the last 3 years, Biodesix's Short term Debt had a median value of $13.1 million in 2023 and averaged $13.8 million.
- As far as peak fluctuations go, Biodesix's Short term Debt soared by 111.36% in 2023, and later crashed by 59.91% in 2024.
- Biodesix's Short term Debt (Quarterly) stood at $17.8 million in 2021, then tumbled by 41.79% to $10.3 million in 2022, then surged by 111.36% to $21.9 million in 2023, then slumped by 59.91% to $5.8 million in 2024.
- Its Short term Debt was $5.8 million in Q2 2024, compared to $19.2 million in Q1 2024 and $21.9 million in Q4 2023.